Johnson & Johnson (JNJ) Revenue Up On Pfizer Unit Purchase
Johnson & Johnson’s (JNJ) revenue rose 13% to $15.1 billion in Q2. However, if revenue from the purchase of Pfizer’s consumer healthcare business was accounted for, the topline would have been up…